{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:04:03Z","timestamp":1792735443998,"version":"4.5.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>This study aimed to determine whether proton craniospinal irradiation (CSI) decreased the dose to normal tissue and resulted in less toxicity than photon CSI for adult patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This single-institution retrospective analyzed differences in radiation doses, acute toxicity, and cost between proton and CSI for adult medulloblastoma patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 39 total patients, 20 were treated with photon CSI prior to 2015, and 19 were treated with proton CSI thereafter. Median age was 28 years (range 18\u201366). The molecular subtype was most commonly sonic hedgehog (68%). Patients most commonly received 36 Gy CSI in 20 fractions with a boost to 54\u201355.8 Gy (92%). Proton CSI delivered significantly lower mean doses to cochleae, lacrimal glands, lens, parotid glands, pharyngeal constrictors, esophagus, lungs, liver, and skin (all P\u2005&amp;lt;\u2005.001). Patients receiving proton CSI had significantly lower rates of acute dysphagia of any grade (5% versus 35%, P\u2005=\u2005.044) and decreased median weight loss during radiation (+1.0 versus \u20132.8\u00a0kg, P\u2005=\u2005.011). Weight loss was associated with acute hospitalization (P\u2005=\u2005.009). Median follow-up was 2.9 and 12.9 years for proton and photon patients, respectively, limiting late toxicity and outcome comparisons. At the last follow-up, 5 photon patients had died (2 of progressive disease, 3 without recurrence ages 41\u201363) and 21% had experienced major cardiovascular events. At 10 years, 89% were alive and 82% were recurrence free.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study demonstrates dosimetric improvements with proton CSI, potentially leading to decreased acute toxicity including dysphagia and weight loss during treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/noajnl\/vdae034","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T09:36:51Z","timestamp":1709890611000},"source":"Crossref","is-referenced-by-count":10,"title":["Proton versus photon craniospinal irradiation for adult medulloblastoma: A dosimetric, toxicity, and exploratory cost analysis"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8039-2398","authenticated-orcid":false,"given":"William G","family":"Breen","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie S","family":"Geno","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R","family":"Waddle","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S","family":"Harmsen","sequence":"additional","affiliation":[{"name":"Department of Biomedical Statistics and Informatics, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry C","family":"Burns","sequence":"additional","affiliation":[{"name":"Department of Neurologic Surgery, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur T","family":"Sener","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W","family":"Ruff","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2342-0000","authenticated-orcid":false,"given":"Bryan J","family":"Neth","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon H","family":"Uhm","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Routman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon J","family":"Kruse","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia N","family":"Laack","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"issue":"11","key":"2024032812560790000_CIT0001","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jocn.2012.04.009","article-title":"The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children","volume":"19","author":"Smoll","year":"2012","journal-title":"J Clin Neurosci."},{"issue":"4","key":"2024032812560790000_CIT0002","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/biomedicines9040356","article-title":"Typical pediatric brain tumors occurring in adults-differences in management and outcome","volume":"9","author":"Greuter","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"2024032812560790000_CIT0003","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/neuonc\/nox155","article-title":"Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)","volume":"20","author":"Beier","year":"2018","journal-title":"Neuro Oncol"},{"issue":"4","key":"2024032812560790000_CIT0004","doi-asserted-by":"crossref","first-page":"100327","DOI":"10.1016\/j.esmoop.2021.100327","article-title":"How we treat medulloblastoma in adults","volume":"6","author":"Franceschi","year":"2021","journal-title":"Esmo Open"},{"issue":"14","key":"2024032812560790000_CIT0005","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.3390\/cancers13143451","article-title":"Development of randomized trials in adults with medulloblastoma-the example of EORTC 1634-BTG\/NOA-23","volume":"13","author":"Hau","year":"2021","journal-title":"Cancers"},{"issue":"21","key":"2024032812560790000_CIT0006","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1002\/cncr.27536","article-title":"Life years lost","volume":"118","author":"Brodin","year":"2012","journal-title":"Cancer."},{"issue":"2","key":"2024032812560790000_CIT0007","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijrobp.2006.12.030","article-title":"Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults","volume":"68","author":"Padovani","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"2","key":"2024032812560790000_CIT0008","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijrobp.2013.01.014","article-title":"Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma","volume":"86","author":"Brown","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"2","key":"2024032812560790000_CIT0009","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/neuonc\/not155","article-title":"Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation","volume":"16","author":"Barney","year":"2014","journal-title":"Neuro Oncol"},{"issue":"1","key":"2024032812560790000_CIT0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijrobp.2015.09.014","article-title":"Clinical outcomes among children with standard-risk medulloblastoma treated with proton and photon radiation therapy: a comparison of disease control and overall survival","volume":"94","author":"Eaton","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"20","key":"2024032812560790000_CIT0011","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1002\/cncr.33774","article-title":"Intellectual functioning among case-matched cohorts of children treated with proton or photon radiation for standard-risk medulloblastoma","volume":"127","author":"Eaton","year":"2021","journal-title":"Cancer."},{"issue":"3","key":"2024032812560790000_CIT0012","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ijrobp.2020.09.049","article-title":"A Multi-institutional comparative analysis of Proton and Photon therapy-induced hematologic toxicity in patients with medulloblastoma","volume":"109","author":"Liu","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"3","key":"2024032812560790000_CIT0013","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1470-2045(15)00167-9","article-title":"Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study","volume":"17","author":"Yock","year":"2016","journal-title":"Lancet Oncol."},{"issue":"2","key":"2024032812560790000_CIT0014","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/cancers14020414","article-title":"The alliance AMBUSH trial: rationale and design","volume":"14","author":"Mahajan","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2024032812560790000_CIT0015","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.ijrobp.2016.03.041","article-title":"Clinically applicable monte carlo-based biological dose optimization for the treatment of head and neck cancers with spot-scanning proton therapy","volume":"95","author":"Wan Chan Tseung","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"3","key":"2024032812560790000_CIT0016","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ijrobp.2019.06.2534","article-title":"Biologic dose and imaging changes in pediatric brain tumor patients receiving spot scanning proton therapy","volume":"105","author":"Roberts","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"2024032812560790000_CIT0017","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12913-017-2327-8","article-title":"Developing a standardized healthcare cost data warehouse","volume":"17","author":"Visscher","year":"2017","journal-title":"BMC Health Serv Res."},{"issue":"11","key":"2024032812560790000_CIT0018","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of Ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med."},{"issue":"1","key":"2024032812560790000_CIT0019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12890-020-01376-4","article-title":"Radiation-induced lung injury: current evidence","volume":"21","author":"Arroyo-Hernandez","year":"2021","journal-title":"BMC Pulm Med."},{"issue":"1","key":"2024032812560790000_CIT0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2217\/fon.15.284","article-title":"Evolving molecular era of childhood medulloblastoma: time to revisit therapy","volume":"12","author":"Khatua","year":"2016","journal-title":"Future Oncol."},{"issue":"6","key":"2024032812560790000_CIT0021","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00401-016-1569-6","article-title":"Risk stratification of childhood medulloblastoma in the molecular era: the current consensus","volume":"131","author":"Ramaswamy","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"5","key":"2024032812560790000_CIT0022","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00401-021-02358-4","article-title":"Subgroup and subtype-specific outcomes in adult medulloblastoma","volume":"142","author":"Coltin","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"5","key":"2024032812560790000_CIT0023","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/jnen\/nlab020","article-title":"Medulloblastoma in adults: cytogenetic phenotypes identify prognostic subgroups","volume":"80","author":"Goschzik","year":"2021","journal-title":"J Neuropathol Exp Neurol."},{"key":"2024032812560790000_CIT0024","doi-asserted-by":"crossref","first-page":"vii144","DOI":"10.1093\/neuonc\/noac209.555","article-title":"Management and long-term outcomes of adults with medulloblastoma","volume":"24","author":"Neth","year":"2022","journal-title":"Neuro Oncol."},{"issue":"5","key":"2024032812560790000_CIT0025","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/pbc.21588","article-title":"Characteristics and outcomes of medulloblastoma in adults","volume":"51","author":"Ang","year":"2008","journal-title":"Pediatr Blood Cancer."},{"issue":"18","key":"2024032812560790000_CIT0026","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-11-0923","article-title":"Hedgehog fights back: mechanisms of acquired resistance against smoothened antagonists","volume":"71","author":"Metcalfe","year":"2011","journal-title":"Cancer Res."},{"issue":"24","key":"2024032812560790000_CIT0027","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.2015.62.2225","article-title":"Smoothened inhibitors in sonic hedgehog subgroup medulloblastoma","volume":"33","author":"Ransohoff","year":"2015","journal-title":"J Clin Oncol."}],"container-title":["Neuro-Oncology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/noa\/advance-article-pdf\/doi\/10.1093\/noajnl\/vdae034\/56907333\/vdae034.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/6\/1\/vdae034\/57106799\/vdae034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/6\/1\/vdae034\/57106799\/vdae034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T12:56:34Z","timestamp":1711630594000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/noa\/article\/doi\/10.1093\/noajnl\/vdae034\/7624293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/noajnl\/vdae034","relation":{},"ISSN":["2632-2498"],"issn-type":[{"value":"2632-2498","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2024,1,1]]},"article-number":"vdae034"}}